What does a high HbA1c result mean?

A high HbA1c result indicates elevated average blood sugar levels over the past 2-3 months, signaling prediabetes (5.7-6.4%) or diabetes (6.5% or higher). This increases your risk for complications like heart disease, nerve damage, and kidney problems, but can be managed through lifestyle changes and medical treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding HbA1c and What Your Results Mean

Hemoglobin A1c, commonly known as HbA1c or A1c, is a blood test that provides a snapshot of your average blood sugar levels over the past two to three months. Unlike a standard glucose test that measures your blood sugar at a single moment, HbA1c reveals how well your body has been managing glucose over time by measuring the percentage of hemoglobin proteins in your red blood cells that have glucose attached to them.

When glucose enters your bloodstream, it naturally binds to hemoglobin in your red blood cells through a process called glycation. The higher your blood sugar levels, the more glucose attaches to hemoglobin. Since red blood cells typically live for about 120 days, measuring glycated hemoglobin provides insight into your blood sugar control over approximately three months.

Understanding your HbA1c levels is crucial for preventing and managing diabetes, as well as reducing your risk of serious health complications. Regular monitoring through comprehensive blood testing can help you track changes and make informed decisions about your health.

HbA1c Levels and Their Clinical Implications

HbA1c LevelCategoryAverage Blood SugarHealth Implications
Below 5.7%Below 5.7%NormalBelow 117 mg/dLLow diabetes risk, maintain healthy lifestyle
5.7-6.4%5.7-6.4%Prediabetes117-137 mg/dLIncreased diabetes risk, lifestyle intervention recommended
6.5% or higher6.5% or higherDiabetes140 mg/dL or higherDiabetes diagnosis, medical management required
Above 7%Above 7%Uncontrolled Diabetes154 mg/dL or higherHigh complication risk, intensive management needed

HbA1c levels correspond to estimated average glucose (eAG) values. Individual targets may vary based on age, health conditions, and other factors.

HbA1c Ranges and Their Clinical Significance

HbA1c results are expressed as a percentage, with each range carrying different implications for your health. Understanding these ranges helps you and your healthcare provider determine the best course of action for managing your blood sugar levels.

Normal Range

An HbA1c level below 5.7% is considered normal. This indicates that your blood sugar levels have been well-controlled over the past few months, and you have a low risk of developing diabetes. However, maintaining optimal metabolic health requires ongoing attention to diet, exercise, and lifestyle factors, even with normal results.

Prediabetes Range

HbA1c levels between 5.7% and 6.4% indicate prediabetes. This means your blood sugar levels are higher than normal but not yet high enough to be diagnosed as diabetes. Prediabetes affects more than 88 million American adults, and without intervention, 15-30% of people with prediabetes will develop Type 2 diabetes within five years.

Diabetes Range

An HbA1c level of 6.5% or higher on two separate tests indicates diabetes. At this level, your body is struggling to manage blood sugar effectively, either due to insufficient insulin production (Type 1 diabetes) or insulin resistance (Type 2 diabetes). Immediate medical attention and comprehensive management are necessary to prevent complications.

Health Risks Associated with High HbA1c

Elevated HbA1c levels signal more than just high blood sugar; they indicate systemic metabolic dysfunction that can damage multiple organ systems. The longer your HbA1c remains elevated, the greater your risk of developing serious complications.

Cardiovascular Complications

High blood sugar damages blood vessels and accelerates atherosclerosis, significantly increasing your risk of heart disease and stroke. Studies show that for every 1% increase in HbA1c above normal, the risk of cardiovascular disease increases by approximately 18%. This includes increased risk of heart attack, stroke, and peripheral artery disease.

Nerve and Kidney Damage

Chronic hyperglycemia damages small blood vessels throughout your body, leading to diabetic neuropathy (nerve damage) and nephropathy (kidney disease). Neuropathy can cause numbness, tingling, and pain, particularly in the feet and hands, while nephropathy can progress to kidney failure requiring dialysis or transplantation.

Vision and Other Complications

Diabetic retinopathy, caused by damage to blood vessels in the retina, is a leading cause of blindness in adults. High HbA1c levels also increase the risk of cataracts, glaucoma, poor wound healing, increased infection risk, and cognitive decline including dementia.

Common Causes of Elevated HbA1c

Understanding what drives high HbA1c levels can help you address the root causes rather than just treating symptoms. Multiple factors can contribute to elevated readings, and often several work together to impair glucose metabolism.

  • Insulin resistance: The most common cause, where cells become less responsive to insulin's signals
  • Poor dietary habits: High intake of refined carbohydrates, sugary foods, and processed foods
  • Sedentary lifestyle: Lack of physical activity reduces insulin sensitivity
  • Excess weight: Particularly abdominal obesity, which promotes insulin resistance
  • Chronic stress: Elevates cortisol levels, which can increase blood sugar
  • Sleep deprivation: Poor sleep quality or insufficient sleep impairs glucose metabolism
  • Certain medications: Including corticosteroids, some diuretics, and certain antipsychotics
  • Medical conditions: PCOS, Cushing's syndrome, pancreatitis, and thyroid disorders
  • Genetic factors: Family history of diabetes increases your risk

Regular monitoring of HbA1c alongside other metabolic markers can help identify these underlying causes and guide targeted interventions. Comprehensive testing that includes inflammatory markers, hormones, and lipid panels provides a complete picture of your metabolic health.

Natural Strategies to Lower HbA1c

The good news is that elevated HbA1c levels can often be reduced through lifestyle modifications. Research shows that comprehensive lifestyle changes can be as effective as medication for many people with prediabetes or early Type 2 diabetes.

Dietary Modifications

Focus on whole, unprocessed foods with a low glycemic index. Prioritize non-starchy vegetables, lean proteins, healthy fats, and complex carbohydrates. Consider strategies like carbohydrate counting, the plate method (filling half your plate with vegetables), or a Mediterranean-style diet, which has been shown to improve HbA1c levels. Timing matters too: eating regular meals and avoiding late-night snacking can improve glucose control.

Exercise and Physical Activity

Both aerobic exercise and resistance training improve insulin sensitivity and lower HbA1c. Aim for at least 150 minutes of moderate-intensity aerobic activity weekly, plus two or more resistance training sessions. Even a 10-minute walk after meals can significantly blunt post-meal glucose spikes. High-intensity interval training (HIIT) has shown particular promise for improving metabolic health efficiently.

Stress Management and Sleep

Chronic stress and poor sleep directly impact blood sugar control. Implement stress-reduction techniques like meditation, deep breathing, or yoga. Prioritize 7-9 hours of quality sleep nightly, maintaining consistent sleep and wake times. Address sleep disorders like sleep apnea, which is strongly linked to insulin resistance and elevated HbA1c.

Medical Treatment Options

When lifestyle modifications alone aren't sufficient to control HbA1c levels, medical interventions become necessary. The choice of treatment depends on your specific situation, including the severity of elevation, presence of symptoms, and other health conditions.

Metformin is typically the first-line medication for Type 2 diabetes, working by reducing glucose production in the liver and improving insulin sensitivity. Other medication classes include sulfonylureas (which stimulate insulin production), GLP-1 receptor agonists (which slow digestion and promote satiety), SGLT2 inhibitors (which help eliminate excess glucose through urine), and insulin therapy for more advanced cases.

Your healthcare provider will consider factors like kidney function, heart health, weight management goals, and potential side effects when selecting medications. Regular monitoring is essential to assess treatment effectiveness and adjust as needed.

Monitoring Your Progress

Tracking your HbA1c levels over time is crucial for understanding whether your management strategies are working. Most people with diabetes should have their HbA1c tested every three months until stable, then every six months. Those with prediabetes benefit from annual testing, though more frequent monitoring can provide valuable feedback on lifestyle interventions.

Beyond HbA1c, comprehensive metabolic testing provides insights into related health markers. Fasting glucose, insulin levels, lipid panels, inflammatory markers like hs-CRP, and kidney function tests paint a complete picture of your metabolic health. Continuous glucose monitors (CGMs) can also provide real-time feedback on how specific foods and activities affect your blood sugar.

Consider keeping a health journal to track your diet, exercise, stress levels, sleep quality, and how you feel. This information, combined with regular biomarker testing, helps you and your healthcare team make informed decisions about your treatment plan.

Taking Action on Your HbA1c Results

A high HbA1c result is a call to action, not a life sentence. Whether you're dealing with prediabetes or diabetes, taking proactive steps now can prevent or delay complications and improve your quality of life. Start with small, sustainable changes: swap refined grains for whole grains, add a daily walk, prioritize sleep, or practice stress management techniques.

Work with your healthcare team to develop a personalized management plan. This might include referrals to specialists like endocrinologists, certified diabetes educators, or registered dietitians. Don't hesitate to ask questions about your results, treatment options, and what you can do to improve your metabolic health.

Remember that improving HbA1c takes time. Since the test reflects a three-month average, you won't see immediate changes. Stay consistent with your healthy habits, monitor your progress regularly, and celebrate small victories along the way. With dedication and the right support, you can achieve better blood sugar control and reduce your risk of complications.

References

  1. American Diabetes Association. (2023). Standards of Medical Care in Diabetes-2023. Diabetes Care, 46(Supplement 1), S1-S291.[Link][DOI]
  2. Nathan, D. M., et al. (2008). Translating the A1C assay into estimated average glucose values. Diabetes Care, 31(8), 1473-1478.[PubMed][DOI]
  3. Stratton, I. M., et al. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 321(7258), 405-412.[PubMed][DOI]
  4. Diabetes Prevention Program Research Group. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393-403.[PubMed][DOI]
  5. Selvin, E., et al. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine, 362(9), 800-811.[PubMed][DOI]
  6. Qaseem, A., et al. (2018). Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians. Annals of Internal Medicine, 168(8), 569-576.[PubMed][DOI]

Frequently Asked Questions

How can I test my HbA1c at home?

You can test your HbA1c at home with SiPhox Health's Core Health Program, which includes HbA1c testing along with other essential metabolic and cardiovascular biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home, with personalized insights to help you understand and improve your metabolic health.

How quickly can HbA1c levels change?

Since HbA1c reflects your average blood sugar over 2-3 months, significant changes typically take at least 3 months to show up in test results. However, you may notice improvements in daily glucose readings and how you feel within weeks of making lifestyle changes.

Can HbA1c be falsely elevated?

Yes, certain conditions can cause falsely elevated HbA1c readings, including anemia, kidney disease, and certain hemoglobin variants. Recent blood transfusions or significant blood loss can also affect results. Your healthcare provider can order additional tests if false elevation is suspected.

What's the difference between HbA1c and fasting glucose?

Fasting glucose measures your blood sugar at a single point in time after not eating for 8-12 hours, while HbA1c provides an average of your blood sugar levels over the past 2-3 months. HbA1c is generally considered more reliable for diagnosing diabetes because it's not affected by recent meals or short-term fluctuations.

Can stress alone cause high HbA1c?

While acute stress typically causes temporary blood sugar spikes, chronic stress can contribute to persistently elevated blood sugar and higher HbA1c levels. Stress hormones like cortisol increase glucose production and can promote insulin resistance over time. Managing stress is an important component of blood sugar control.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details